Royalty Pharma plc Treasury Stock, Value
Royalty Pharma plc (RPRX) had Treasury Stock, Value of $2.66 million as of 2024-12-31, per its 10-K filed 2025-02-12.
Financial Statements › Balance Sheet › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent › Treasury Stock, Value
us-gaap:TreasuryStockValue · last filed 2025-02-12
- 2024-12-31: Treasury Stock, Value $2.66M.
- 2024-09-30: Treasury Stock, Value $2.66M.
- 2024-06-30: Treasury Stock, Value $2.66M.
- 2024-03-31: Treasury Stock, Value $2.65M.
| Period end | Treasury Stock, Value |
|---|---|
| 2024-12-31 | $2.66M 10-K · filed 2025-02-12 |
| 2024-09-30 | $2.66M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $2.66M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $2.65M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $2.63M 10-K · filed 2025-02-12 |
| 2023-09-30 | $2.62M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $2.63M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $2.83M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $2.81M 10-K · filed 2024-02-15 |
| 2022-09-30 | $2.79M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $2.75M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $2.74M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $2.71M 10-K · filed 2023-02-15 |
| 2021-09-30 | $2.69M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $2.66M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $2.36M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $2.32M 10-K · filed 2022-02-15 |
| 2020-09-30 | $2.15M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $2.12M 10-Q · filed 2020-08-12 |
| 2019-12-31 | $4.27M 10-K · filed 2021-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |